Experts Go Toe-to-Toe Over Esketamine Depression Study - Medscape
Click here to read source article from Medscape.com
Summary
The ongoing debate over the risks and benefits of recently approved esketamine nasal spray for treatment-resistant depression spilled over into a heated discussion at the APA 2019 Annual Meeting.
My Thoughts
Medscape strikes again with another great article. New technologies never cease to amaze me and I am excited to see what the future holds. If this is what is happening in 2018 can you image what the world is going to be like in 2025?
Thank you for Reading!
This has been your health news update. Thank you so much for reading. I do my best to bring Steem the most up to date news. Please don't forget to leave your thoughts and comments below.